Rationale: MultiStem is an allogeneic bone marrow-derived adherent adult stem cell product that has shown efficacy in preclinical models of acute myocardial infarction (AMI). In this phase I clinical trial in patients with first ST-elevation-myocardial infarction (STEMI), we combine first-in-man delivery of MultiStem with a first-in-coronary adventitial delivery system to determine the effects of this system on left ventricular function at 4 months after AMI.
Objective: Test the effects of adventitial delivery of Multistem in the peri-infarct period in patients with first STEMI.
Aims: Previous risk models predicting in-hospital major adverse cardiac or cerebrovascular events (MACCE) after percutaneous coronary interventions (PCI) may underestimate actual short-term post-procedure complications due to the trend toward early discharge of patients.
Methods And Results: Using a subset (N=10,679) from the STENT Group registry, a logistic regression model was developed to predict 30-day MACCE which includes death, myocardial infarction, target vessel revascularisation and stroke. An integer-based risk score was created from the model and validated in another subset (N=3,099).
Monaldi Arch Chest Dis
May 2002
Background: We were interested in the feasibility of existing valid specific health-related quality of life [HRQL] instruments, designed for patients with heart failure, angina pectoris, or myocardial infarction [MI], being used to make outcome comparisons among pure or mixed populations of patients with these heart disease diagnoses.
Methods: A battery of specific HRQL questionnaires, including the Minnesota Living with Heart Failure questionnaire, the Seattle Angina Questionnaire, the MacNew Heart Disease questionnaire, the generic SF-36 health status survey, and the Hospital Anxiety and Depression Scale, was mailed to the 205 patients with current mailing addresses and returned by 161 patients [78.5%].
To evaluate the results percutaneous transluminal coronary angioplasty (PTCA), intravascular ultrasound imaging was performed in 32 proximal coronary arterial segments and in 16 atherosclerotic lesions after PTCA in 13 patients using a 5 Fr balloon catheter with an ultrasound transducer mounted just proximal to the balloon. Simultaneous angiographic measurements of vessel diameter were also performed using electronic calipers from contrast cine angiograms. There was good correlation between ultrasound and angiographic minimum luminal diameters of the normal proximal vessel (y = 0.
View Article and Find Full Text PDFThe growth of coronary angioplasty has resulted in increased fluoroscopy time to patients, staff, and physicians. Rapid exchange-type catheters have purported to reduce fluoroscopy time and procedure time compared to conventional over-the-wire systems. Of 150 consecutive patients, 54 were treated solely with rapid-exchange catheters and 84 were treated solely with over-the-wire catheters.
View Article and Find Full Text PDF